Nishan de Silva
2012
In 2012, Nishan de Silva earned a total compensation of $1.3M as VP, Finance and Strategy and Chief Financial Officer at Ligand Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $98,508 |
|---|---|
| Option Awards | $803,223 |
| Salary | $246,269 |
| Stock Awards | $144,700 |
| Other | $39,067 |
| Total | $1,331,767 |
de Silva received $803.2K in option awards, accounting for 60% of the total pay in 2012.
de Silva also received $98.5K in non-equity incentive plan, $246.3K in salary, $144.7K in stock awards and $39.1K in other compensation.
Rankings
In 2012, Nishan de Silva's compensation ranked 5,007th out of 11,487 executives tracked by ExecPay. In other words, de Silva earned more than 56.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,007 out of 11,487 | 56th |
Division Manufacturing | 1,753 out of 4,253 | 59th |
Major group Chemicals And Allied Products | 418 out of 1,198 | 65th |
Industry group Drugs | 270 out of 920 | 71st |
Industry Pharmaceutical Preparations | 212 out of 700 | 70th |
Source: SEC filing on March 12, 2015.
de Silva's colleagues
We found four more compensation records of executives who worked with Nishan de Silva at Ligand Pharmaceuticals in 2012.